You would think that a restructure of the company would now look favourable, given the price of copper.The administrators should send out some info prior to the end of the financial year. (that is what they said in their circular, dated 12 Mar 09)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%